*Dr. Mushtak T. S Al-Ouqaili **Dr. Yasin Hamad Majeed

Slides:



Advertisements
Similar presentations
Delta virus infection in Iraq Clinical & immunological characteristics Aswad Habeeb Hameed Al-Obeidy FICMS GE & Hep.
Advertisements

Hepatitis B & Hepatitis C in HIV
HCV Assays: Impact on HCV Studies & Update on HCV blood bank protocol.
National Institute for Biological Standards and Control Assuring the quality of biological medicines Proposal for a Hepatitis A genotype panel Rob Anderson.
Advances in the Treatment of Chronic Hepatitis C Gregory T Everson, MD Professor of Medicine Director of Hepatology University of Colorado Denver.
6/03/031 Hepatitis C –Update Laboratory Issues Hema Kapoor MD. SM Virology Section Manager Bureau of Laboratories Michigan Department of Community Health.
Improved Reflexive Testing Algorithm for Hepatitis C Infection Using Signal-to-Cutoff Ratios of a Hepatitis C Virus Antibody Assay K.K.Y. Lai, M. Jin,
Hepatitis C virus seroprevalence in Russian Federation: results of population based study Preliminary report K.Kyuregyan, N.Soboleva, V.Kichatova, O.Isaeva,
Carolyn A. Ragland August Hepatitis C *Paraenterally transmitted Contact with infected blood / blood products Blood transfusions – no longer the.
H EPATITIS VIRUS A & B Presented By: Dora Amoako Gerardo Castro.
Laboratory Investigation
Hepatitis Viruses Chapter 35. Properties of Hepatitis Viruses Six known Hepatitis type A virus (Picornaviridae) Hepatitis type B virus (Hepadnaviridae)
Prabhdeep Sidhu Candidate PharmD 2015 Western University of Health Sciences Mar 28, 2014.
1 MicroRNA Silencing of Tumor Suppressor DLC-1 Promotes Efficient Hepatitis C Virus Replication in Primary Human Hepatocytes 指導老師:鄭伯智老師、林宏榮老師 學生:林怡君 (N99H0005)
HEPATITIS C VIRUS Presented By: Rabia Ejaz Tahira Karim Hafsa Iftikhar.
Hepatitis C Virus  Genome resembled that of a flavivirus positive stranded RNA genome of around 10,000 bases  1 single reading frame, structural genes.
HCV PCR By Henrietta Orji July 31 st, 2010 Hepatitis C Virus by Polymerase Chain Reaction.
LOWERING THE DETECTION LIMITS OF HIV-1 VIRAL LOAD USING REAL-TIME IMMUNO-PCR FOR HIV-1 P24 ANTIGEN Niel T. Constantine, Ph.D., Daniel Edelman, M.S., Janet.
Clinical case 19 Lin, I-Yao (Sally). Case 19 Having been confined in the hospital for almost a month due recurrent pneumonia, Mr. XXX, 42 y/o, married,
Hepatitis C A Growing Problem of Pakistan. Group Members Zoya Imran Mariam Archer Nawal Nawaz Sidra Tul Muntaha.
professor in microbiology
Hepatitis Virus. Primary members HAV HBV HCV HDV HEV.
Susan L. Uprichard, PhD Director of Hepatology Research Loyola University Medical Center Department of Medicine Section of Hepatology HepNet 2013 HCV Virology.
HEPATITIS C VIRUS INFECTION AMONG PATIENTS AT HOSPITAL TENGKU AMPUAN AFZAN, KUANTAN: GENOTYPES DISTRIBUTION AND RNA SEQUENCE VARIATION.
Parallel and Overlapping Prevalence of Hepatitis B and C Viruses in Apparently Healthy Individuals in a Northern Nigerian Population Pennap, GRI and Chuga,
بسم الله الرحمن الرحيم Community Medicine Lec -11-
INTRODUCTION & OBJECTIVES Introduction: The carcinogenesis of hepatocellular carcinoma (HCC) is a multifactorial, multistep and complex process. Its prognosis.
MICROBIOLOGY IRS. Gastroenteritis 1) Major cause of infantile death 2) Feacal-oral transmission 3) Gastroenteritis cause dehydration 4) 50 % of all causes.
Template ID: junglegreens Size: 36x48 Impact of Hepatitis C Screening in Outpatient Population Madhuri Chandnani MD, Pallavi Pothuri MD, Michael Stevens.
Hepatitis C Molecular Diagnosis in the Era of DAAs July 22, 2016, Tehran Ali Namvar Ph.D of Molecular Genetics Iranian Comprehensive Hemophilia Care Center.
Treatment of HBV/HCV Coinfection
A REVIEW ON HIV DIAGONOSTIC TEST
Hepatitis viruses.
Hepatitis Viruses.
Hepatitis C: Overview and Epidemiology
VIRAL INFLUENZA.
Dr. Iram Shad PGT-Medicine MU-1, HFH,RWP
Effectiveness of Sofosbuvir in terms of sustained virological response at 12 weeks after treatment (SVR12) BETWEEN treatment naïve AND treatment.
In The Name of God.
Ann Intern Med. 2017;167(1):1-7. doi: /M Figure Legend:
HCV by PCR Neelam Gajjar 7/26/2009.
The Value of Measurement of Circulating Tumor Cells in Hepatocellular Carcinoma Nashwa Sheble, Gehan Hamdy, Moones A Obada, Gamal Y Abouria, Fatma Khalaf.
Dr Iyat Abdul Sattar A study on the clinical & serolological markers of HBV among patients with chronic HBV infection in Babylon Dr Monem Makki Alshok.
HEPATITIS VIRUSES Part 2.
PREVALENCE OF HEPATITIS B VIRUS INFECTION AMONG FEDERAL
Prevalence of Hepatitis C Virus Genotypes in Bangladesh
Hepatitis C Virus RNA Real-Time Quantitative RT-PCR Method Based on a New Primer Design Strategy  Lida Chen, Wenli Li, Kuo Zhang, Rui Zhang, Tian Lu,
1.
Cascade of care for persons newly diagnosed
Vrushali Patwardhan, Dinesh Kumar, Varun Goel, Sarman Singh
LAB. DIAGNOSIS OF VIRUSES
Diagnosis and Point of Care Testing of Hepatitis C
Laboratory Diagnosis of Infectious Diseases
Minimal Residual Disease (MRD) Detection Technologies
Presented By: Sally Saad Mandour Esawy
BY DR. MUDAMA PRECIOUS (M.B.B.S., BENIN)
HCV. The Spectrum of Hepatitis C Virus Infection: From Acute Infection to End-Stage Liver Disease.
Hepatitis C Virus RNA Real-Time Quantitative RT-PCR Method Based on a New Primer Design Strategy  Lida Chen, Wenli Li, Kuo Zhang, Rui Zhang, Tian Lu,
PHARMACOTHERAPY III PHCY 510
Chronic Hepatitis C Therapy: Changing the Rules of Duration
Jeffrey J. Germer, BS, Nizar N. Zein, MD  Mayo Clinic Proceedings 
Division of Viral Hepatitis
HEPATITIS C BY MBBSPPT.COM
Introduction To Medical Technology
A Real Life Study on Treatment of Egyptian Patients with HCV Genotype IV with Simeprevir and Sofosbuvir Prof.dr.Abdel fattah hanno Dr. Doaa al wazzan.
Division of Viral Hepatitis, CDC
Development and Validation of a Template-Independent Next-Generation Sequencing Assay for Detecting Low-Level Resistance-Associated Variants of Hepatitis.
Chronic Hepatitis C Therapy: Changing the Rules of Duration
Management Of Lassa Fever in a Resource Limited Setting: Experience From Irrua Specialist Teaching Hospital Main author: Gloria Esoimeme Co-authors:
بسم الله الرحمن الرحيم.
Presentation transcript:

*Dr. Mushtak T. S Al-Ouqaili **Dr. Yasin Hamad Majeed Based on Molecular level, A Study of Hepatitis C in AL-Anbar Governorate, West of Iraq By:- *Dr. Mushtak T. S Al-Ouqaili **Dr. Yasin Hamad Majeed *Assistant Professor, Dean of College of Pharmacy, University of Al-Anbar **Lecture, Dep. Of Intern. Med., College of Medicine, University of Al-Anbar

بِسمِ اللهِ الرَّحمن الرَّحِيمِ {فَأَمَّا الزَّبَدُ فَيَذْهَبُ جُفَاءً وَأَمَّا مَا يَنفَعُ النَّاسَ فَيَمْكُثُ فِي الأَرْضِ كَذَلِكَ يَضْرِبُ اللَّهُ الأَمْثَال} صَدَقَ اللهُ العَظيمْ

Introduction

Introduction Hepatitis C virus (HCV) infection is one of the main causes of chronic liver disease worldwide. It is estimated that approximately 130–210 million individuals i.e. 3% of the world population, are chronically infected with HCV.

Hepatitis C Virus

HCV Structure RNA virus Virion: Single-stranded Enveloped Positive-sense 9400 nucleotide Virion: Enveloped Icosahedral capsid 40-60 nm in diameter

HCV Genome 1 hypervariable region: E1, E2 envelope proteins Allows for evasion of host immunologic response 9400 nucleotide, single ORF Codes for a viral polyprotein about 3000 a.a. in length 3 highly conserved areas: 5’ UTR: initiating translation Core: codes for capsid protein monomer 3’ UTR: essential for RNA synthesis & packaging

Pathology of HCV Acute Hepatitis C: Generally benign: No jaundice (80%) Usually asymptomatic Can be severe, but liver failure rare Only real threat of acute Hepatitis C is its ability to reach chronic stages undetected and untreated.

Pathology of HCV Chronic Hepatitis C: 70% of patients become chronic Possible results: Cirrhosis End-stage liver disease Hepatocellular carcinoma

Aims of this study

Aims of this study This study has been undertaken for the following purposes:- 1:- Preliminary screening for hepatitis C virus infection depending on immunochromatographic essay and enzyme linked immunosorbent essay. 2:- Detection of HCV-RNA copies through determination of viral load by real time polymerase chain reaction (RT-PCR)

Aims of this study 3:- Genotyping of HCV-RNA using Smart Cycler Genotyper. 4:- Follow up of Patients infected with hepatitis C virus before and after treatment using quantitative real time PCR.

Patients & methods

Method Plan Laboratory Part Serological Part Molecular Part

Methods A total of 105 patients with suspicion of hepatitis C infection were studied during the period from January, 2012 and till now. They were well diagnosed by experient clinician during admitting GIT Centre in Ramadi Teaching Hospital and Private Clinics.

The clinical samples were submitted for immunochromatographic essay and enzyme linked immunosorbent (ELISA) essay as preliminary screening tests.

Confirmatory test include reverse transcriptase real time polymerase chain reaction (RT-PCR) were used to detect viral load for HCV-RNA copies considering the lower sensitivity threshold was 200 copy/ml in addition to follow up the quantity of nucleic acid copies after period of therapeutic regimen using the same instrument.

Also, advanced molecular technique include genotyping to detect HCV-RNA genotypes into (1, 2, 3, 4, 5, and 6) was achieved.

Results & Discussion

Results and Discussion The study result revealed that all study patients, 105 (100%) were positive by dipstick assay which depends on its mechanism on immunochromatographic essay. Of these, 91 (86.7%) patients were appeared to be positive for anti-hepatitis C virus antibodies by ELISA. the study patients

Results and Discussion Out of these patients, 73 (80.2%) had observed number of HCV-RNA by RT-PCR with mean 5.34E+06 ± 5.34E+06 IU/ml (1.81E+07 ± 3.87E+07 copy/ml) while the remaining 18 (19.8%) showed undetectable HCV-RNA copies (Less than lower sensitivity threshold, 200 copy/ml).

Statistical parameters   Mean 5.34E+06 1.81E+07 Median 1.22E+06 4.88E+06 Std. Deviation 1.22E+07 3.87E+07 Minimum 1.70E+02 6.80E+02 Maximum 7.49E+07 2.18E+08

Results and Discussion In genotyping study, positive HCV-RT-PCR patients were yielded as follow: 56 (76.7%) with genotype 4, 14 (19.2%) genotype 1 while 3 (4.2%) were positive for genotype 3. On the other hand, in term of quantitative RT-PCR, out of study patients, 19 (20.8%) were submitted to follow up before and after treatment with ribavirin and interferon. They showed sharp decrease in HCV-RNA copies count.

In Iraq, the prevalence of HCV ranged from 3. 21 to 7 In Iraq, the prevalence of HCV ranged from 3.21 to 7.1% among the pregnant women and general population of four HCV genotypes, 1a, 1b, and 3a and 4. A study carried out on Iraqi refuges showed further discrepancy in this regard; The researcher showed that by using HCV-RNA analysis found that the prevalence among these refuges was 0.1%, and HCV genotype 4c, d was the commonest.

HCV is less frequent among Lebanese; it ranged from 0. 16 to 1 HCV is less frequent among Lebanese; it ranged from 0.16 to 1.22% among healthy volunteers, blood donors, and health care workers, though it was 27% among haemodialysis patients. Genotype 4 was the commonest isolated genotype among the various groups studied followed by genotypes 1a and 1b. The above results were in consistent with our study results.

Conclusions & Recommendations

Conclusions ELISA was reliable confirmatory test for detection of anti-hepatitis C virus antibodies. On molecular level, RT-PCR was a cut-off diagnostic tool for confirmation of HCV infection. 3-It is so beneficial in the follow up of patients to monitor therapeutic response depending on the amount of HCV-RNA copies. 4-HCV-genotype 4 was the most common among study patients followed by genotype 1 and 3 respectively.

Aknowledgment Special thanks and deep gratitude to my colleague the experient gastroenterologist Dr. Yasin Hamad Majeed, Lecturer in Department of Internal Medicine, College of Medicine, University of Anbar for his scientific efforts in providing the work clinical specimens and and scientific contribution in all study details

Thank you for Listening